Oswari, Jane, Michael A. Matthay, and Susan S. Margulies. Keratinocyte growth factor reduces alveolar epithelial susceptibility to in vitro mechanical deformation. Am J Physiol Lung Cell Mol Physiol 281: L1068-L1077, 2001.-Keratinocyte growth factor (KGF) is a potent mitogen that prevents lung epithelial injury in vivo. We hypothesized that KGF treatment reduces ventilator-induced lung injury by increasing the alveolar epithelial tolerance to mechanical strain. We evaluated the effects of in vivo KGF treatment to rats on the response of alveolar type II (ATII) cells to in vitro controlled, uniform deformation. KGF (5 mg/kg) or saline (no-treatment control) was instilled intratracheally in rats, and ATII cells were isolated 48 h later. After 24 h in culture, both cell groups were exposed to 1 h of continuous cyclic strain (25% change in surface area); undeformed wells were included as controls. Cytotoxicity was evaluated quantitatively with fluorescent immunocytochemistry. There was Ͼ1% cell death in undeformed KGF-treated and control groups. KGF pretreatment significantly reduced deformation-related cell mortality to only 2.2 Ϯ 1.3% (SD) from 49 Ϯ 5.5% in control wells (P Ͻ 0.001). Effects of extracellular matrix, actin cytoskeleton, and phenotype of KGF-treated and control cells were examined. The large reduction in deformation-induced cell death demonstrates that KGF protects ATII cells by increasing their strain tolerance and supports KGF treatment as a potential preventative measure for ventilator-induced lung injury. acute lung injury; barotrauma; mechanical ventilation; mechanotransduction MECHANICAL VENTILATION is used to care for patients with acute respiratory failure. Although this treatment provides ventilatory support, it can worsen lung injury (5, 37) . The effects of high pressures and excessive regional lung volumes can result in life-threatening barotrauma or ventilator-induced lung injury (VILI) (27) . Potential mechanisms involved in the onset of VILI have included repeated collapse and reopening of the airspaces (30) , inflammation and neutrophil influx (18) , and surfactant inactivation (39) . Numerous animal studies in the last decade (6, 11, 12, 19, 23, 25, 34) have shown that ventilation with high volumes or airway pressures can induce air leaks, compromise the blood-gas barrier, cause alveolar cell dysfunction, and increase pulmonary edema as well as reduce fluid clearance. Alveolar epithelial injury alone can potentiate pulmonary edema formation even in the presence of normal pulmonary microvascular pressure, plasma oncotic pressure, and endothelial permeability (17) .
The recent positive results from the National Institutes of Health-sponsored ventilator management study conducted by the Acute Respiratory Distress Syndrome Network demonstrated that mechanical ventilation with a low tidal volume (6 ml/kg predicted body wt) and a plateau pressure limit (Ͻ30 cmH 2 O) reduced patient mortality by 22% compared with a traditional tidal volume (12 ml/kg) (5) . These findings emphasize the value of experimental models to determine the mechanisms that make the epithelium susceptible to mechanical deformation and to define interventions that protect the epithelium against mechanical deformation. In a previous publication, Tschumperlin et al. (33) examined the relative effects of deformation frequency, duration, and amplitude on cell viability in vitro (33) . Cellular injury seemed to occur rapidly, specifically in the first 5 min of cyclic deformation. Deformation-induced injury increased with the frequency of sustained cyclic deformations but was not dependent on the strain rate during a single deformation. When the amplitude of deformation was reduced by superimposing small cyclic deformations on a tonic deformation, cell death was significantly reduced compared with large amplitude deformations with the same peak deformation. This evidence supports the recently published Acute Respiratory Distress Syndrome Network data (5) stating that ventilation with lower tidal volumes but significantly higher positive end-expiratory pressures resulted in lower mortality rates than traditional tidal volume ventilation. These clinical studies confirm the importance of in vitro models in helping to determine the etiology of VILI and develop new therapies for the prevention and treatment of VILI.
After injury to the alveolar epithelium, alveolar type II (ATII) cells proliferate in vivo and eventually differentiate into type I (ATI) cells that line the alveolar epithelium to restore the parenchymal structure (21) .
Keratinocyte growth factor (KGF) is a known potent mitogen of ATII cells after treatment in vivo (14, 24, 35, 36) , suggesting a role for KGF in the repair of the alveolar epithelium after lung injury. KGF may also enhance alveolar fluid clearance after acute lung injury by upregulating sodium pump expression and transepithelial sodium transport across the alveolar epithelium (2). It has also been shown to induce an increase in mRNA expression of surfactant protein (SP) A and SP-B after their addition to ATII cells in culture (29) , demonstrating a potential role in reversing surfactant dysfunction. KGF can also accelerate wound closure in airway epithelium during cyclic mechanical strain (38) and thus may also enhance epithelial recovery after VILI. Recent evidence (42) demonstrated that KGF pretreatment reduced edema during ex vivo inflations at large tidal volumes. These studies have directed us to evaluate the role of KGF treatment in vivo on the prevention of VILI by measuring the viability of treated and untreated ATII cells exposed to controlled mechanical deformations approximately equivalent to those experienced during large tidal volumes. Previous work by Tschumperlin and Margulies (31) demonstrated the vulnerability of untreated alveolar epithelial cells to deformation 1 and 5 days after isolation. Increasing deformation amplitude was associated with an increasing proportion of nonviable cells after 1 h of cyclic deformation. Untreated cells were most vulnerable after 1 day in culture, but by 5 days, their tolerance to strain had increased significantly. We hypothesized that the specific mechanism involved in the increased tolerance of untreated cells by day 5 may yield insight into developing new modalities to prevent VILI.
Therefore, the purpose of this study was to measure the role KGF can play in altering the vulnerability of the alveolar epithelium to mechanical deformation and to identify the potential contributions of extracellular matrix (ECM) composition, the actin cytoskeleton, and the phenotype of the alveolar epithelium. Our objective was to determine whether KGF may serve as a cytoprotective strategy as evidenced by enhanced epithelial tolerance to mechanical deformation in vitro.
MATERIALS AND METHODS
Experimental matrix. The experimental matrix consisted of three integrated studies. In the first study, ATII cells seeded on fibronectin-coated elastic membranes were harvested 48 h after instillation with KGF or saline vehicle; after 24 h in culture, they were biaxially strained cyclically in a continuous manner. Cell viability was examined in biaxially strained and in undeformed wells to determine whether KGF instillation enhanced alveolar epithelial resistance to deformation. Comparison with the data in the previously published study by Tschumperlin and Margulies (31) in untreated ATII cells after 1 or 5 days in culture demonstrated no effect due to the saline vehicle, and the remaining untreated control groups in our study consisted of animals receiving no instillation. To examine the specific contribution of the ECM to the cellular response to biaxial strain, in the second study, untreated cells were seeded on ECM obtained from treated cells or untreated cells after 5 days in culture, and their viability, cytoskeleton (F-actin), and phenotype were compared with treated and untreated cells seeded on fibronectin. In the third study, the distinct phenotype and cytoskeleton of treated cells were characterized and compared with those of untreated cells at 1 and 5 days and then correlated with the viability data to evaluate these factors as potential contributors to the cellular deformation tolerance of KGF-treated cells.
KGF or saline instillation. Ten male Sprague-Dawley rats (Charles River, Wilmington, MA) weighing 140-160 g were anesthetized with methoxyfluorane (Mallinckrodt Veterinary, Mundelein, IL). Seven rats received a single intratracheal injection of KGF (5 mg/kg body wt in 0.4 ml of saline plus 0.6 ml of air) and three rats served as controls, receiving a single intratracheal injection of saline alone (0.4 ml plus 0.6 ml of air). ATII cells were isolated 48 h after instillation. Recombinant KGF was generously provided by Dr. Michael Matthay's laboratory (University of California, San Francisco) in collaboration with Amgen (Thousand Oaks, CA). Seven rats that received no intratracheal instillation were used as additional controls for ECM, phenotype, and actin studies.
Cell isolation. The animals were anesthetized with pentobarbital sodium (50 mg/kg body wt intraperitoneally). The trachea was cannulated, the lungs were mechanically ventilated, an abdominal aortotomy was performed, and the lungs were perfused via the pulmonary artery to remove blood. The lungs were excised, and the ATII cells were dissociated and isolated with a technique adapted from Dobbs et al. (10) . Briefly, the cells were dissociated with elastase (3 U/ml; Worthington Biochemical, Lakewood, NJ) and minced with a tissue chopper. Cell separation was done by filtration through progressively smaller mesh sizes (400, 160, and 37 m; Crosswire Cloth, Bellmawr, NJ) and then centrifuged for 10 min at 1,000 rpm. The cells were plated on a bacteriological petri dish precoated with rat IgG (3 mg in 5 ml of Tris ⅐ HCl; Sigma, St. Louis, MO). After a 1-h incubation at 37°C in 5% CO2, the ATII cells were isolated from the macrophages and contaminating cells by gentle panning (10) . ATII cell yield was usually doubled 48 h after KGF instillation compared with that in untreated animals, indicating the mitogenic effect of KGF.
Cell culture. ATII cells were resuspended in DMEM supplemented with 10% fetal bovine serum, 25 g/ml of gentamicin (GIBCO BRL, Life Technologies, Grand Island, NY), and 0.25 g/ml of amphotericin B (Sigma). For all conditions, the cells were plated at a density of 1.0 ϫ 10 6 cells/cm 2 on Silastic membranes (Specialty Manufacturing, Saginaw, MI) mounted into our custom-made wells with O-rings (31). Cell attachment was limited to the central portion of each membrane by placing a piece of Tygon tubing (ϳ1-cm diameter) in the center of each well and seeding cells only within this restricted area. This region was coated with fibronectin (40 g/ml; Boehringer Mannheim Biochemicals, Indianapolis, IN) to assist cell attachment. Cell purity, assessed by phosphine 3R staining of adherent cells after 24 h in culture, was Ͼ95% (22) . The cells were studied after 24 h in culture.
Cell deformation. After 24 h in culture, eight wells from every isolation were washed with serum-free DMEM supplemented with 1% penicillin (1,000 U/ml) and streptomycin (10 mg/ml; GIBCO BRL), in which sodium bicarbonate was replaced with 20 mM HEPES. Four of the wells were mounted in a custom-designed cell-stretching device previously described and validated (31) . The wells were biaxially strained at 25% change in surface area (⌬SA) for 1 h at 15 cycles/min, equivalent to inflation to ϳ80% of total lung capacity (32) . Four no-stretch control wells from each isolation were main-tained within the device during the experimental period. Experiments were carried out at 37°C in room air. After deformation, three of the strained wells were tested for viability and one was fixed for F-actin analysis. For the unstrained control wells, two were used to test viability and two were fixed for phenotypic characterization. These studies included 24-h cells from the KGF instillation, 24-h untreated cells on KGF ECM, and 24-h untreated cells on day 5 matrix. All viability data are reported as percent dead cells normalized by unstrained control cells.
Cell viability. Before cellular deformation, ethidium homodimer-1 and calcein-AM (LIVE/DEAD kit, Molecular Probes) were added to the cells at a final concentration of 0.23 and 0.12 M, respectively. Ethidium homodimer-1 (excitation ϳ495 nm and emission ϳ635 nm), which is excluded by the intact plasma membrane of live cells, enters cells with damaged membranes and undergoes a fluorescence enhancement on binding to nucleic acids. Calcein-AM (excitation ϳ495 nm and emission ϳ515 nm), a cell-permeant dye, is retained within live cells. One hour after the onset of biaxial strain, control and deformed wells were examined with an inverted epifluorescence microscope (ϫ20 objective, TE-300, Nikon), and images of the cells were captured with a digital imaging system (Hammamatsu, Metamorph 3.0 software, Universal Imaging). Images were acquired from three random locations in the well at both emissions for visualizing ethidium homodimer-1 and calcein-AM (Fig. 1) . These images were subsequently analyzed by counting stained cells, and nonviable cells are reported as a percentage of the total number of cells. Results across all wells in an experimental group were averaged and are expressed as means Ϯ SD. Comparisons between specific experimental groups were evaluated with unpaired Student's and Welch's approximate t-tests.
Phenotype. To determine whether the phenotype of the cells was related to their response to biaxial strain, two complementary phenotypic markers were evaluated in unstrained cells from every experimental group. Cells from two to four isolations in each group were evaluated for each marker. The phenotype of isolated alveolar epithelial cells was examined at isolation (day 0) and on day 1 (24 h in culture) and compared with the phenotype evaluated in untreated cells maintained in culture for 5 days. Day 0 cells were cytospun onto slides for immunocytochemistry. Day 1 and day 5 cells were stained in our custom-made wells. Specifically, we used an ATI cell-specific monoclonal antibody to RTI 40 and an ATII-specific polyclonal antibody to proSP-C. RTI 40 (antibody was a gift from Dr. L. Dobbs, University of California, San Francisco) is a 40-to 42-kDa protein that is specific in the lung to the apical plasma membrane of the rat ATI cell (16) . The antibody to proSP-C (a gift from Dr. M. Beers, Children's Hospital of Philadelphia, Philadelphia, PA) labels a precursor of SP-C (1), a lung-specific, hydrophobic peptide found in pulmonary surfactant and synthesized by ATII cells. Although SP-A, SP-B, and SP-D are also made by Clara cells in the lung, SP-C is specific to ATII cells and appears in abundance.
Cells were fixed with 4% paraformaldehyde for 20 min and treated with sodium borohydride (1 mg/ml; Sigma) to reduce endogenous fluorescence. Normal goat serum (GIBCO BRL) was used to block nonspecific sites. Primary antibodies were incubated at room temperature for 1 h. Fluorescein-conjugated and Texas Red-X-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) were incubated at room temperature for 2 h in the dark. Immunofluorescence was preserved with fluorescent mounting medium (DAKO, Carpinteria, CA), and the slides were stored at 4°C.
In our freshly isolated, untreated ATII cells, we confirmed that proSP-C was present in large quantities, whereas RTI 40 levels were very low, with occasional ATI cells contaminating the isolation as others have found (7) . The proportion of positively stained cells was quantified in treated and untreated cells maintained in culture for 1 day, untreated cells maintained in culture for 5 days, and untreated cells seeded onto each ECM material (see Isolating ECM) and maintained in culture for 1 day. Images from three randomly selected fields were captured from proSP-C-and RTI 40-stained slides (1-3 slides/antibody) in each experimental group as previously described in Cell viability for viability analysis. Positively stained cells were counted in each field and are reported as a percentage of the total number of cells in the field. Results across all fields in an experimental group were averaged and are expressed as means Ϯ SD (see Fig. 4 ). Comparisons between experimental groups were evaluated by Tukey-Kramer test for multiple comparisons.
Isolating ECM. Freshly isolated untreated ATII cells were seeded on the ECM of KGF-instilled cells (n ϭ 3 animals) or untreated day 5 alveolar epithelial cells (n ϭ 4 animals). KGF or day 5 cells were washed with Hanks' balanced salt solution (HBSS) to remove any medium or fetal bovine serum. The cells were then treated with 0.5% Triton X-100 supplemented with 5 mM EDTA for 5 min. The cells were then rinsed off with HBSS three times, leaving behind their ECM. Sterile tubing pieces were then placed over the ECM, and freshly isolated untreated cells were seeded within the center of each well at 1 ϫ 10 6 cells/cm 2 . The cells were incubated for 24 h at 37°C in 5% CO2.
F-actin. Biaxially strained and undeformed control wells were stained for F-actin with Oregon Green 488 phalloidin (Molecular Probes, Eugene, OR). At least three isolations from each experimental group were used to analyze F-actin distribution. The cells were fixed with 4% paraformaldehyde for 20 min. The cell membranes were permeabilized with 0.1% Triton X-100, and 1% BSA (Sigma) was used to block nonspecific sites. Oregon Green 488 phalloidin was diluted to 5 U/ml and incubated with the cells at room temperature for 20 min. The cells were washed with HBSS, mounted onto a slide, and preserved with fluorescent mounting medium (DAKO).
RESULTS
Viability results. KGF significantly reduced the cell death of ATII cells induced by mechanical deformation (Figs. 1 and 2) . Strain-induced viability values were obtained by subtracting the viability of paired, timematched unstrained control cells from the same isolation and experimental group from the viability of the biaxially strained cells. Thus all reported viability data for strain conditions have been normalized by the unstrained control values for that respective experiment. Specifically, after continuous cyclic (15 cycles/min) deformation (25% ⌬SA) equivalent to the average deformation of the epithelium during a tidal volume of ϳ80% of total lung capacity (32) for 1 h, only 2.2 Ϯ 1.3% of KGF-instilled cells were nonviable (n ϭ 15 wells) compared with 49 Ϯ 5.5% nonviable in the salinetreated cells (P Ͻ 0.001; n ϭ 6 wells). Unstrained control wells for KGF and saline instillation were 0.74 Ϯ 0.9 (n ϭ 10 wells) and 0.99 Ϯ 0.36% (n ϭ 4 wells) nonviable, respectively. Cell death with saline instillation for undeformed (2.2%) and biaxially strained (49%) conditions were not significantly different from the historic findings by Tschumperlin and Margulies (31) without instillation [3.4 Ϯ 0.6% nonviable without deformation (n ϭ 3 wells) and 43.6 Ϯ 6.6% deformed with the identical protocol (n ϭ 7 wells); P Ͼ 0.10 and Ͼ 0.20, respectively], demonstrating that the saline vehicle alone had no effect on cell viability. Consequently, untreated control measurements for ECM, phenotype, and actin evaluation were made with the cells from animals with no saline instillation.
The effect of the ECM on the susceptibility of ATII cells after mechanical deformation was also analyzed. Untreated ATII cells were seeded on the ECM isolated from day 1 KGF-treated cells or untreated day 5 cells. After a 1-h biaxial strain at 25% ⌬SA, the proportion of nonviable ATII cells seeded on day 5 ECM was significantly reduced to 3.2 Ϯ 2.8% (n ϭ 11 wells) compared with ATII cells seeded on fibronectin alone (43.6 Ϯ 6.6% nonviable; n ϭ 7 wells). Interestingly, under the same strain conditions, the percent of nonviable ATII cells on KGF-treated ECM was 41.7 Ϯ 3.6 (n ϭ 7 wells), not significantly different from untreated cells seeded on fibronectin alone.
Phenotype characterization. Two phenotypic markers were evaluated in unstrained cells from every experimental group with antibodies to RTI 40 (specific to ATI cells) and proSP-C (specific to ATII cells). Freshly isolated (day 0) untreated ATII cells expressed proSP-C strongly but lost this characteristic by day 5 in culture and, conversely, expressed little RTI 40 at isolation but showed a progressive increase by day 5 (Fig. 3) . These levels in untreated day 1 and day 5 cells were used to establish the extremes of a continuum between type II and type I phenotypes and, as a backdrop, to describe the effect of KGF instillation or ECM on phenotype in our quantitative analysis in Fig. 4 .
KGF instillation significantly accelerated the progression of ATII cells to the ATI phenotype, which was at an intermediate phenotype after 24 h in culture. Specifically, the proportion of cells staining positive for RTI 40 was indistinguishable from that of day 5 cells, but proSP-C staining still indicated the ATII phenotype of day 1 cells. These findings are consistent with the hypothesis that loss of the ATII phenotype contributed to the enhanced viability described in Fig. 2 characteristic of day 1 cells in culture (see Fig. 6A ). By day 5 in culture, the cell boundaries were practically indistinguishable due to a loss of the peripheral actin band and the interior fibers were shorter and more networked (see Fig. 6E ). These cytoskeletal changes observed in untreated cells provided the rationale for determining the actin cytoskeletal distribution in cells after KGF instillation and its potential contribution to enhanced cell viability. After 24 h in culture, cells harvested after KGF instillation showed an actin distribution somewhere between that of day 1 and day 5 untreated cells (see Fig. 6B ). Stress fibers were still evident but shorter, and cell boundaries were less distinct. These results are consistent with our phenotype results, demonstrating that KGF instillation can accelerate the transition toward a type I-like cell.
Because there were distinctive alterations in the actin distribution, we hypothesized that reducing the networked F-actin architecture of KGF-instilled cells with latrunculin A would decrease the tolerance of the cells to mechanical strain. Latrunculin A, an actinspecific agent, sequesters the monomeric G-actin pool, thereby preventing polymerization to F-actin. In a preliminary study, KGF-instilled cells maintained in culture for 1 day were treated with latrunculin A (0.03 g/ml for 1 h). As anticipated, the actin distribution was focused around the periphery of the cell, with few stress fibers present, thus demonstrating that latrunculin A prevented the formation of F-actin (see Fig. 7 ). In contrast to our hypothesis, unpaired Student's t-test analysis demonstrated that the latrunculin A-treated, KGF-instilled cells showed a very small but significant reduction in cell death (0.12 Ϯ 0.21% nonviable) compared with untreated KGF-instilled cells (2.20 Ϯ 1.25% nonviable; P ϭ 1.7 ϫ 10 Ϫ5 ), consistent with enhanced tolerance to mechanical strain when F-actin is reduced. We concluded that it is possible that the enhanced viability of the KGF-treated cells compared with uninstilled control cells may be related to other components of the cytoskeleton such as the intermediate filaments, the microtubules, or a combination of systems.
The F-actin was also analyzed in untreated day 1 cells on either a KGF-treated ECM or a day 5 ECM to evaluate the potential correlation between an ATI actin arrangement and enhanced tolerance to deformation. In fact, ATII cells on KGF-treated ECM (with high cell death) had moderate peripheral staining and some stress fibers similar to ATII cells on fibronectin (see Fig. 6C ). However, in contrast to our hypothesis, cells on day 5 ECM (with low cell death) also had some stress fibers as well as some peripheral staining (see Fig. 6D ), also more similar to ATII cells on fibronectin alone than to day 5 cells.
After 1 h of cyclic biaxial strain at 25% ⌬SA, all cell groups experienced similar, pronounced actin cytoskeletal changes: fewer distinct intracellular fibers and more pronounced subcortical peripheral band (see Fig. 8 ).
To summarize, although ECM may modulate cell viability and phenotype, it does not modulate cytoskel- etal arrangement. However, both cytoskeleton and phenotype data show that KGF instillation hastens the transformation from ATII to ATI characteristics by 24 h in culture.
DISCUSSION
Administration of KGF by intratracheal instillation induces proliferation of alveolar epithelial cells (14, 35, 36) and thus may promote repair of the damaged alveolar epithelium after acute lung injury. Furthermore, KGF instillation has been demonstrated to have a protective effect, reducing pulmonary injury and mortality associated with exposure to bleomycin (28, 45) , hyperoxia (24) , large tidal volumes (42) , and hydrochloric acid instillation (44) . These preclinical studies demonstrating that KGF has a cytoprotective effect are consistent with our findings in this study that KGF reduced alveolar epithelial cell death associated with mechanical deformation.
We examined the role of the ECM, cell phenotype, and actin cytoskeleton of alveolar epithelial cells isolated from KGF-treated animals to identify the specific sites responsible for their enhanced tolerance to cyclic equibiaxial distortions. Previous findings by Tschumperlin and Margulies (31) showed that ATII cells maintained in primary culture for 5 days were significantly more tolerant of deformation than after 1 day (Fig. 2) . This foundation, coupled with evidence that the ECM components of ATII cells in culture change from entirely fibronectin at 1 day to a composite containing fibronectin, laminin, and trace amounts of type IV collagen by 3 and 6 days in culture (13) , led us to hypothesize that the ECM was a major contributing factor to enhanced viability in day 5 untreated and day 1 KGF-treated cells (Fig. 2) . Freshly isolated cells were seeded on ECM obtained from either day 5 untreated cells or KGF-treated cells and compared with cells seeded on fibronectin. The results were mixed (Fig. 2) ; the cells seeded on the ECM of day 5 cells showed the most rapid phenotypic change and a significant reduction in cell death after deformation, but those on KGFtreated ECM had an intermediate phenotype, with deformation-induced cell death rates that were similar to cells seeded directly on fibronectin. Thus, although the ECM of day 5 cells seems to correlate with a reduction in deformation-induced cell death, the ECM of treated cells did not contribute to the enhanced tolerance associated with KGF instillation.
In untreated cells after isolation, the progression of cell differentiation from type II to type I over days in culture has been well documented (3, 7, 9) . To determine the phenotype of the cells, we evaluated two complementary molecular markers in unstrained preparations. As expected, our freshly isolated (day 0) and day 1 untreated ATII cells expressed proSP-C (ATII marker) strongly and lost this characteristic by day 5 in culture. Conversely, the cells expressed little RTI 40 (ATI marker) at isolation but showed a progressive increase by day 5 (Figs. 3 and 4) . Projected onto this continuum, we evaluated the relative effect of KGF or alterations in ECM by comparing the RTI 40 and proSP-C levels on day 1 in these treatment groups compared with untreated control cells. KGF treatment in vivo accelerates the progression of ATII cells to the ATI phenotype such that by 24 h in culture, their phenotypic alterations are between those for untreated day 1 and day 5 cells. Together with the enhanced viability of day 5 cells, these findings are consistent with the conclusion that the enhanced viability described in Figs. 1 and 2 after KGF instillation is at least partially attributable to the loss of ATII phenotype.
Our results are similar to those of Fehrenbach et al. (14) , who demonstrated with immunohistochemistry of lung parenchyma that a single in vivo KGF treatment (5 mg/kg body wt) stimulated cell differentiation from the ATII to the ATI phenotype. Our studies indicate that the in vivo KGF treatment 24 h before cell isolation also causes a more rapid transition in culture to the type I phenotype. In contrast, when cells were exposed after isolation to KGF in vitro from day 0 or day 4 in culture to day 8, Borok et al. (3) noted decreased expression of aquaporin 5, a water channel present in freshly isolated ATI cell membranes but not in ATII cells. In untreated cells, aquaporin 5 increased over days in culture, but KGF treatment in vitro inhibited or reversed this temporal progression. Possible explanations for this disparity may include 100,000 times higher KGF concentrations in the instillate and in vivo secondary mediators that were not present during in vitro treatment.
To evaluate the potential correlation between phenotype and cell viability more closely, we examined the phenotype of untreated ATII cells on the ECM from KGF-instilled cells (high cell death) and from day 5 untreated cells (low cell death; see Figs. 4 and 5) . The phenotype of both groups demonstrate ATI-type levels of RTI 40 , but KGF-treated ECM had transitional levels of proSP-C, whereas day 5 ECM had progressed to ATI levels of proSP-C as well. Taken together, these results demonstrated that the ECM had a significant effect on the phenotype of these cells after 24 h in culture but that the phenotype of the cells on alternative ECM did not correlate closely with the viability in these groups. Interestingly, after a longer period (72 h) in culture, Lwebuga-Mukasa et al. (20) observed enhanced transformation to an ATI morphology when adult epithelial ATII cells were seeded on human lung basement membrane compared with those on either tissue culture plastic or amnion.
The F-actin cytoskeleton has been linked to transducing external mechanical stimuli and regulating cell function (8, 40) and has been shown to respond to physical forces applied to the cell and be important in cellular resistance to imposed stresses (41). Thus we hypothesized that the F-actin cytoskeletal arrangement may be altered in KGF-treated cells and that this structural change may contribute to the enhanced viability of KGF-instilled cells exposed to biaxial strain. Furthermore, this latter hypothesis was supported by our data demonstrating that untreated cells on day 1 and day 5 in culture have specific cytoskeletal arrangements. Specifically, on day 1, we observed distinct peripheral bands of actin along with long stress fibers, but by day 5, cell boundaries were almost indistinguishable and the actin fibers were shorter and more networked (see Fig. 6 ). Consistent with this hypothesis, we expected that the actin in the KGF-instilled cells would be similar to that in day 5 untreated cells. We found that the actin in KGF-instilled cells had stress fibers (characteristic of untreated cells on day 1) but also had shorter, more networked actin fibers and a less distinct peripheral band, typical of day 5 cells. Thus, consistent with the phenotype data, KGF seemed to accelerate the progression of ATII cells to develop ATI cell features but that actin arrangement does not consistently correlate with viability. We conclude that the enhanced viability of the KGF-treated cells may be related to other components of the cytoskeleton such as the intermediate filaments, the microtubules, or a combination of systems.
In addition to Borok et al. (2, 3) , other investigators have exposed cells to KGF after isolation in an in vitro setting and have demonstrated a reduction in lung injury due to H 2 O 2 and radiation exposure (26, 43) and accelerated repair after epithelial injury (38) . For comparative purposes, we conducted a limited investigation to evaluate the viability of alveolar epithelial cells harvested from untreated lungs after in vitro KGF treatment. At the time of seeding the cells onto fibronectin-coated membranes, KGF [0, 10 (2, 3), or 50 (38) ng/ml] was added to the medium. After 1 day in culture, these cells were exposed to the same deformation protocol described in MATERIALS AND METHODS, and the proportion of nonviable cells is expressed relative to unstrained control and untreated control cells (data not shown). There was no significant dose response such that the tolerance of the cells to biaxial strain was not significantly enhanced with the in vitro KGF treatment at either concentration (P Ͼ 0.05). Thus the dramatic in vivo response, with the lack of an in vitro effect, may be attributed to differences in KGF concentration (as discussed above), shorter exposure time (48-h exposure in vivo vs. 24 h in vitro), or secondary mediator factors present only in vivo. The in vitro treatment time was selected to allow for comparison with all of our formal experimental groups in which the cells were studied after 24 h in culture. Thus we conclude that comparisons between in vivo and in vitro KGF preparations must be made cautiously and that results obtained in an in vitro model should be reconfirmed in vivo before extension to the clinical setting.
The mechanism for the cytoprotective effect on alveolar epithelial cells may relate to changes in the phenotype, ECM components, or the cytoskeleton of ATII cells or to other aspects of the mechanotransduction pathway of the cell. For example, the ECM is closely associated with cytoskeletal mechanotransduction, and integrins (4, 15) transduce forces between the cytoskeleton from the ECM. Our results indicate that by 5 days in culture or after 24 h on day 5 ECM, cells have an ATI-type phenotype based on two markers, and they develop a significant resistance to deformation-induced death compared with cells after 1 day in culture (31) . This phenomenon of increased resistance was also observed after a single instillation of KGF, yet the phenotype of these cells was at an intermediate stage between ATII and ATI. Although the specific mechanism involved is still unknown, we do know that the cytoskeleton and the ECM play a role. Future studies are needed to address these mechanisms and their relationships with each other.
Previously, Tschumperlin and Margulies (31) showed that in vitro cyclic biaxial mechanical deformation causes rapid cell death in ATII cells after 1 day in culture. In this study, we found that a single in vivo treatment with KGF has a dramatic effect in the reduction in cell death from in vitro mechanical deformation. These findings support the potential role of KGF treatment as a protective measure for deformationinduced alveolar epithelial injuries associated with VILI. Finally, this study provides insight into new preventative therapies in addition to a reduction in tidal volume (5) to decrease the high morbidity and mortality rates related to ventilator-associated lung injury.
